2020 Patient Support / Hub Services Report

Patient support services—supported directly or indirectly by pharma companies—have gone from a ‘nice to have’ feature to a ‘must have’ one in recent years. The reasons are not hard to find: the growth of specialty pharmaceuticals (now representing nearly half […]

Read More

Gathering to take stock of hub services

The trend toward manufacturer-sponsored patient support has risen in line with the growth of specialty pharmaceuticals: those drugs have a host of obstacles, including prior authorization review, dispensing complexity, adherence difficulties and—certainly not least—reimbursement challenges. For a decade and more, […]

Read More